All News
Article |

How a Lack of Transparency Could Cost You

Tis the season… open enrollment season! HR & employee benefit professionals across the country are eating, sleeping, and breathing their benefit package as their members make their selections for the upcoming year. Having crafted this year’s benefit package, they’re answering questions, connecting with vendors, following up, and making notes for next year already. Benefit professionals are hearing it all, but one question seems to recur: Where is my money going?  

Decision makers should be asking this same question when building the benefit in the first place. Depending on your PBM partner, you may have a hard time finding an answer. It’s no secret that healthcare costs continue to rise. Yet when it comes to pharmacy benefits, many organizations have limited visibility into where their money is actually being spent, and therefore no answer as to why their costs are going up.

For years, pharmacy benefit management has operated behind a curtain of complex contracts, pricing arrangements, rebate structures, and financial terminology that can be difficult to navigate. At the end of the day, plan sponsors receive reports showing what they spent, but very little insight into why.

Pharmacy Benefits Aren't Just About Prescription Drug Costs

When employers think about pharmacy spending, most focus on the price of medications, but prescription drug costs represent only one part of the equation. Step one is to evaluate the two types of PBM models and ensure your PBM operates on the transparent or pass-through model. 

From there, depending on the model, additional revenue streams may include:

  • Administrative fees
  • Manufacturer rebates
  • Network discounts
  • Specialty pharmacy arrangements
  • Spread pricing structures
  • Clinical program fees

Understanding how each of these components works is essential when evaluating the true cost of a pharmacy benefit. When employers don't have this visibility into the financial mechanics of their benefit, it becomes difficult to answer basic questions such as:

  • Where are rebates being directed?
  • How is the PBM compensated?
  • What savings opportunities exist?
  • Which medications, members, and pharmacies are driving spend?
  • Are clinical programs delivering value?

Without these answers, pharmacy benefit management becomes largely reactive. Organizations are left reviewing costs after they occur rather than proactively managing them. And getting caught on your heels never feels great. 

Beyond the Fee Schedule

New age PBMs operate on the transparent model, charging flat, upfront fees that outline exactly where and why you’re being charged. This outlined fee schedule is the base for financial accountability, and if your PBM isn’t providing this or you have to (sometimes repeatedly) ask for it, that should tell you something. 

Beyond the basics of a fee schedule, uncovering where your dollars go also comes down to where they’re not going. Are you spending more on brand medications and less on generics? Why is that? Do you have a biosimilar strategy in place? Are you prioritizing the most cost-effective pharmacies? Oftentimes, comprehensive reporting can uncover additional savings opportunities that might go unrealized unless you’re able to look at the full picture.

When equipped with meaningful insights, employers can better understand specialty drug trends and merging cost drivers, biosimilar opportunities, GLP-1 utilization (which can be a big driver of spend), clinical intervention results, member engagement patterns, and more.

This supports more strategic decision-making and helps organizations stay ahead of future challenges.

Regardless of PBM partner, employers should feel comfortable asking these key questions:

  • How does the PBM make money?
  • Are all rebates passed through?
  • What fees exist beyond administration costs?
  • What reporting is available?
  • How are savings opportunities identified?
  • Can financial performance be independently validated?

A trusted PBM partner should welcome these questions.

Why Alignment Matters

Once every cost is uncovered, it comes down to one thing, that just so happens to be one of the most overlooked aspects of pharmacy benefit management: incentive alignment. If a PBM's financial success depends on higher utilization or retained revenue streams, employers should at minimum understand that dynamic.

The goal is a joint partnership in which employers can make informed decisions with confidence. Understanding where pharmacy dollars go shouldn't require a degree in finance or contract law. Employers deserve a clear understanding of how their pharmacy benefit operates, how their PBM is compensated, and where opportunities for savings exist. When a PBM operates on a pass-through model with clearly defined administration fees, the financial relationship becomes much easier to understand.

MedOne was founded in 1999 on the concept of transparency and has since kept this core feature at the forefront of our operations. We believe better visibility leads to better decisions. And better decisions help create better outcomes for members and plan sponsors alike.